These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7047855)
1. [Prevention of cardiovascular diseases]. Akhmeteli MA Kardiologiia; 1982 May; 22(5):47-54. PubMed ID: 7047855 [No Abstract] [Full Text] [Related]
2. [Short-term pilot study of the feasibility of multifactor reduction of coronary risk]. Menotti A; Puddu V G Ital Cardiol; 1973; 3(2):206-19. PubMed ID: 4197329 [No Abstract] [Full Text] [Related]
3. Strategy, yield and risks of controlling plasma lipids in the primary prevention of coronary heart disease. Oliver MF Adv Exp Med Biol; 1985; 183():225-40. PubMed ID: 3898747 [No Abstract] [Full Text] [Related]
4. Prevention of coronary heart disease--propaganda, promises, problems, and prospects. Oliver MF Circulation; 1986 Jan; 73(1):1-9. PubMed ID: 3510083 [No Abstract] [Full Text] [Related]
7. Current status of coronary prevention. Lessons from the Framingham study. Dawber TR; Kannel WB Prev Med; 1972 Dec; 1(4):499-512. PubMed ID: 4670405 [No Abstract] [Full Text] [Related]
8. [Experiences of 15 years in the screening of ischaemic heart diseases and arterial hypertension]. Santrůcek M; Geizerová H; Hejl Z; Grafnetter D Z Gesamte Inn Med; 1975 Nov; 30(21):709-13. PubMed ID: 1210471 [TBL] [Abstract][Full Text] [Related]
9. Cholesterol, coronaries, clofibrate and death. Oliver MF N Engl J Med; 1978 Dec; 299(24):1360-2. PubMed ID: 362204 [No Abstract] [Full Text] [Related]
10. [Study of clofibrate. The opinion of Prof. D. Kritchevsky]. Fabbrocini V Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692 [No Abstract] [Full Text] [Related]
11. [Real or alleged risks of clofibrate derivatives and certain risks of their prohibition]. de Gennes JL Nouv Presse Med; 1979 Mar; 8(15):1223-5. PubMed ID: 375186 [No Abstract] [Full Text] [Related]
12. [Is hypolipemic treatment effective as a preventive measure?]. Rywik S Przegl Lek; 1989; 46(7):619-23. PubMed ID: 2685917 [No Abstract] [Full Text] [Related]
13. Prevention of ischaemic heart disease. Possibilities and problems. Fejfar Z; Vanĕcek R Rev Czech Med; 1970; 16(4):161-70. PubMed ID: 5491480 [No Abstract] [Full Text] [Related]
14. The multiple risk factor intervention trial (MRFIT). A national study of primary prevention of coronary heart disease. JAMA; 1976 Feb; 235(8):825-7. PubMed ID: 946311 [No Abstract] [Full Text] [Related]
15. [Therapy and prevention of arteriosclerosis]. Gerö S Z Alternsforsch; 1971; 24(4):301-20. PubMed ID: 4110936 [No Abstract] [Full Text] [Related]
16. [Prevention of arteriosclerotic heart and vascular diseases]. Siedek H Wien Med Wochenschr; 1971 Jul; 121(30):575-81. PubMed ID: 5564652 [No Abstract] [Full Text] [Related]
17. International trends in coronary heart disease epidemiology. Epstein FH Ann Clin Res; 1971 Dec; 3(6):293-9. PubMed ID: 5156889 [No Abstract] [Full Text] [Related]
19. Strategy of prevention: lessons from cardiovascular disease. Rose G Br Med J (Clin Res Ed); 1981 Jun; 282(6279):1847-51. PubMed ID: 6786649 [No Abstract] [Full Text] [Related]
20. Primary prevention of coronary heart disease. A socio-pediatric problem. de Haas JH Maandschr Kindergeneeskd; 1973 Apr; 41(1):37-52. PubMed ID: 4577898 [No Abstract] [Full Text] [Related] [Next] [New Search]